Log In
Print
BCIQ
Print
Print this Print this
 

Edarbyclor, Azilsartan medoxomil/chlorthalidone

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionFixed-dose combination of azilsartan medoxomil, an angiotensin II type 1 (AT1) receptor blocker, and chlorthalidone, a long-acting oral thiazide-like diuretic
Molecular Target Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

Partner

Arbor Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today